Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer’s Disease and Vascular Dementia
Background: It has been suggested that circulating Paraoxonase-1 (PON1) and apolipoprotein A1 (APOA1), which closely interacts with the antioxidant enzyme, could be implicated in Alzheimer’s disease (AD) and vascular dementia (VaD) development. This study aimed to evaluate PON1 changes in serum and...
Main Authors: | Arianna Romani, Alessandro Trentini, Wiesje M. van der Flier, Tiziana Bellini, Giovanni Zuliani, Carlo Cervellati, Charlotte E. Teunissen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/9/5/456 |
Similar Items
-
Evaluation of paraoxonase, arylesterase, and homocysteine thiolactonase activities in patients with diabetes and incipient diabetes nephropathy
by: Ayan Durmu§, et al.
Published: (2019-01-01) -
Serum arylesterase and paraoxonase activities in patients with ovarian tumors
by: Slawomir Michalak, et al.
Published: (2014-12-01) -
Paraoxonase and Arylesterase activities of human serum paraoxonase in coronary artery disease
by: Abdolkarim Mahrooz, et al.
Published: (2008-11-01) -
Total oxidative stress, paraoxonase and arylesterase levels at patients with pseudoexfoliation syndrome and pseudoexfoliative glaucoma
by: Feyza Dursun, et al.
Published: (2015-10-01) -
Total oxidant status, total antioxidant status, and paraoxonase and arylesterase activities during laparoscopic cholecystectomy
by: Hande Koksal, et al.
Published: (2010-01-01)